The total return over the past 12 months is +72.59% vs. +16.94% for the S&P 500. So far it's up +59.99% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +72.59% | +14.67% | +25.08% | N/A | N/A | N/A |
| Total Return CAGR | +72.59% | +14.67% | +25.08% | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Vaxcyte, Inc. (PCVX)
| Year | Start price | End price | PCVX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $46.14 | $73.82 | +59.99% | +14.51% | +45.48% |
| 2025 | $81.86 | $46.14 | (43.64%) | +17.72% | (61.36%) |
| 2024 | $62.80 | $81.86 | +30.35% | +24.89% | +5.46% |
| 2023 | $47.95 | $62.80 | +30.97% | +26.19% | +4.78% |
| 2022 | $23.79 | $47.95 | +101.56% | (18.17%) | +119.73% |
| 2021 | $26.57 | $23.79 | (10.46%) | +28.74% | (39.20%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
